Dongsung Pharm (002210) - Total Liabilities

Latest as of June 2025: ₩107.40 Billion KRW ≈ $72.78 Million USD

Based on the latest financial reports, Dongsung Pharm (002210) has total liabilities worth ₩107.40 Billion KRW (≈ $72.78 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002210 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Dongsung Pharm - Total Liabilities Trend (2008–2024)

This chart illustrates how Dongsung Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Dongsung Pharm total assets.

Dongsung Pharm Competitors by Total Liabilities

The table below lists competitors of Dongsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Atech OEM TWO:6109	Taiwan	NT$422.67 Million
PJX Resources Inc V:PJX	Canada	CA$275.29K
ODTech Co. Ltd KQ:080520	Korea	₩7.53 Billion
Jullundur Motor Agency (Delhi) Limited NSE:JMA	India	Rs-2.78 Billion
Turk Ilac ve Serum Sanayi AS IS:TRILC	Turkey	TL4.21 Billion
SMRT Holdings Bhd KLSE:0117	Malaysia	RM16.64 Million
Desane Group Holdings Ltd AU:DGH	Australia	AU$35.11 Million
Fun Yours Technology Co Ltd TWO:6482	Taiwan	NT$153.98 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Dongsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Dongsung Pharm balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dongsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dongsung Pharm (2008–2024)

The table below shows the annual total liabilities of Dongsung Pharm from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.73 Billion ≈ $65.56 Million	+28.69%
2023-12-31	₩75.17 Billion ≈ $50.94 Million	+15.84%
2022-12-31	₩64.89 Billion ≈ $43.98 Million	+11.61%
2021-12-31	₩58.14 Billion ≈ $39.40 Million	-17.84%
2020-12-31	₩70.77 Billion ≈ $47.96 Million	+14.83%
2019-12-31	₩61.63 Billion ≈ $41.77 Million	-25.49%
2018-12-31	₩82.71 Billion ≈ $56.05 Million	+38.05%
2017-12-31	₩59.91 Billion ≈ $40.60 Million	-14.12%
2016-12-31	₩69.77 Billion ≈ $47.28 Million	+8.37%
2011-12-31	₩64.38 Billion ≈ $43.63 Million	-6.30%
2010-12-31	₩68.71 Billion ≈ $46.56 Million	+14.63%
2009-12-31	₩59.94 Billion ≈ $40.62 Million	+5.62%
2008-12-31	₩56.75 Billion ≈ $38.46 Million	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$22.30 Million

₩32.90 Billion KRW

Market Cap Rank

#24850 Global

#1794 in Korea

Share Price

₩1348.00

Change (1 day)

-0.15%

52-Week Range

₩973.00 - ₩1688.00

All Time High

₩45800.00